McKesson (MCK) Stock Forecast & Price Target

Compare

2,158 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MCK Analyst Ratings

Strong Buy

11 Buy

2 Hold

0 Sell

Based on 13 analysts giving stock ratings to

McKesson

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MCK Stock 12 Month Forecast

Average Price Target

$942.83

▲(15.74% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for McKesson in the last 3 months. The average price target is $942.83 with a high forecast of $1,000.00 and a low forecast of $880.00. The average price target represents a 15.74% change from the last price of $814.63.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"566":"$566","1001":"$1,001","674.75":"$674.8","783.5":"$783.5","892.25":"$892.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1000,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.00K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":942.83,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$942.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":880,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$880.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[566,674.75,783.5,892.25,1001],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,820.29,834.1138461538461,847.9376923076923,861.7615384615384,875.5853846153846,889.4092307692307,903.2330769230769,917.0569230769231,930.8807692307693,944.7046153846154,958.5284615384616,972.3523076923077,986.1761538461539,{"y":1000,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,820.29,829.7161538461538,839.1423076923077,848.5684615384615,857.9946153846154,867.4207692307692,876.8469230769231,886.2730769230769,895.6992307692308,905.1253846153846,914.5515384615385,923.9776923076923,933.4038461538462,{"y":942.83,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,820.29,824.8830769230769,829.4761538461538,834.0692307692308,838.6623076923076,843.2553846153846,847.8484615384615,852.4415384615385,857.0346153846153,861.6276923076923,866.2207692307692,870.8138461538462,875.406923076923,{"y":880,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":567.508,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":592.243,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":637.562,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":671.595,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":704.573,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":720.217,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":726.194,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":697.315,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":685.181,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":764.368,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":810.584,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":856.89,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":820.29,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$1,000.00

Average Price Target$942.83

Lowest Price Target$880.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Allen Lutz

Bank of America Securities

$950

Buy

16.62%

Upside

Reiterated

01/05/26

Analysts Offer Insights on Healthcare Companies: McKesson (NYSE: MCK) and Protagonist Therapeutics (NASDAQ: PTGX)

Charles Rhyee

TD Cowen

$1,000

Buy

22.76%

Upside

Reiterated

12/22/25

Analysts Are Bullish on These Healthcare Stocks: COMPASS Pathways (CMPS), McKesson (MCK)

Steven Valiquette

Mizuho Securities

$820.25→$880

Hold

8.02%

Upside

Reiterated

12/22/25

Mizuho Securities Remains a Hold on McKesson (MCK)

George Hill

Deutsche Bank

$861→$904

Buy

10.97%

Upside

Reiterated

12/10/25

McKesson price target raised to $904 from $861 at Deutsche BankMcKesson price target raised to $904 from $861 at Deutsche Bank

Glen Santangelo

Barclays

$960

Buy

17.84%

Upside

Initiated

12/08/25

McKesson initiated with an Overweight at BarclaysMcKesson initiated with an Overweight at Barclays

Stephen Baxter

Wells Fargo

$816→$914

Hold

12.20%

Upside

Reiterated

11/10/25

Analysts Offer Insights on Healthcare Companies: Moderna (NASDAQ: MRNA), McKesson (NYSE: MCK) and Lexicon Pharmaceuticals (NASDAQ: LXRX)

Lisa Gill

J.P. Morgan

$853→$983

Buy

20.67%

Upside

Reiterated

11/07/25

McKesson (MCK) Gets a Buy from J.P. Morgan

Erin Wright

Morgan Stanley

$857→$916

Buy

12.44%

Upside

Reiterated

11/06/25

McKesson price target raised to $916 from $857 at Morgan StanleyMcKesson price target raised to $916 from $857 at Morgan Stanley

Eric Coldwell

Robert W. Baird

$873→$927

Buy

13.79%

Upside

Reiterated

11/06/25

McKesson price target raised to $927 from $873 at BairdMcKesson price target raised to $927 from $873 at Baird

Kevin Caliendo

UBS

$920→$980

Buy

20.30%

Upside

Reiterated

11/06/25

McKesson (MCK) Gets a Buy from UBS

Elizabeth Anderson CFA

Evercore ISI

$825→$1,000

Buy

22.76%

Upside

Reiterated

11/06/25

Evercore ISI Remains a Buy on McKesson (MCK)

Unknown Analyst

William O'Neil

Not Ranked

William O'Neil

Buy

―

Initiated

10/17/25

McKesson (MCK) Initiated with a Buy at William O'Neil

Brian Tanquilut

Jefferies

$820→$900

Buy

10.48%

Upside

Reiterated

10/13/25

McKesson's Strategic Initiatives and Growth Potential Justify Buy Rating and Increased Price Target

Michael Cherny

Leerink Partners

Buy

―

Reiterated

10/06/25

Leerink Partners Reaffirms Their Buy Rating on McKesson (MCK)

Daniel Grosslight

Citi

$820→$860

Buy

5.57%

Upside

Reiterated

09/24/25

McKesson price target raised to $860 from $820 at CitiMcKesson price target raised to $860 from $820 at Citi

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Allen Lutz

Bank of America Securities

$950

Buy

16.62%

Upside

Reiterated

01/05/26

Analysts Offer Insights on Healthcare Companies: McKesson (NYSE: MCK) and Protagonist Therapeutics (NASDAQ: PTGX)

Charles Rhyee

TD Cowen

$1,000

Buy

22.76%

Upside

Reiterated

12/22/25

Analysts Are Bullish on These Healthcare Stocks: COMPASS Pathways (CMPS), McKesson (MCK)

Steven Valiquette

Mizuho Securities

$820.25→$880

Hold

8.02%

Upside

Reiterated

12/22/25

Mizuho Securities Remains a Hold on McKesson (MCK)

George Hill

Deutsche Bank

$861→$904

Buy

10.97%

Upside

Reiterated

12/10/25

McKesson price target raised to $904 from $861 at Deutsche BankMcKesson price target raised to $904 from $861 at Deutsche Bank

Glen Santangelo

Barclays

$960

Buy

17.84%

Upside

Initiated

12/08/25

McKesson initiated with an Overweight at BarclaysMcKesson initiated with an Overweight at Barclays

Stephen Baxter

Wells Fargo

$816→$914

Hold

12.20%

Upside

Reiterated

11/10/25

Analysts Offer Insights on Healthcare Companies: Moderna (NASDAQ: MRNA), McKesson (NYSE: MCK) and Lexicon Pharmaceuticals (NASDAQ: LXRX)

Lisa Gill

J.P. Morgan

$853→$983

Buy

20.67%

Upside

Reiterated

11/07/25

McKesson (MCK) Gets a Buy from J.P. Morgan

Erin Wright

Morgan Stanley

$857→$916

Buy

12.44%

Upside

Reiterated

11/06/25

McKesson price target raised to $916 from $857 at Morgan StanleyMcKesson price target raised to $916 from $857 at Morgan Stanley

Eric Coldwell

Robert W. Baird

$873→$927

Buy

13.79%

Upside

Reiterated

11/06/25

McKesson price target raised to $927 from $873 at BairdMcKesson price target raised to $927 from $873 at Baird

Kevin Caliendo

UBS

$920→$980

Buy

20.30%

Upside

Reiterated

11/06/25

McKesson (MCK) Gets a Buy from UBS

Elizabeth Anderson CFA

Evercore ISI

$825→$1,000

Buy

22.76%

Upside

Reiterated

11/06/25

Evercore ISI Remains a Buy on McKesson (MCK)

Unknown Analyst

William O'Neil

Not Ranked

William O'Neil

Buy

―

Initiated

10/17/25

McKesson (MCK) Initiated with a Buy at William O'Neil

Brian Tanquilut

Jefferies

$820→$900

Buy

10.48%

Upside

Reiterated

10/13/25

McKesson's Strategic Initiatives and Growth Potential Justify Buy Rating and Increased Price Target

Michael Cherny

Leerink Partners

Buy

―

Reiterated

10/06/25

Leerink Partners Reaffirms Their Buy Rating on McKesson (MCK)

Daniel Grosslight

Citi

$820→$860

Buy

5.57%

Upside

Reiterated

09/24/25

McKesson price target raised to $860 from $820 at CitiMcKesson price target raised to $860 from $820 at Citi

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering McKesson

1 Month

xxx

Success Rate

21/31 ratings generated profit

Average Return

+2.33%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 67.74% of your transactions generating a profit, with an average return of +2.33% per trade.

3 Months

xxx

Success Rate

24/31 ratings generated profit

Average Return

+8.38%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 77.42% of your transactions generating a profit, with an average return of +8.38% per trade.

1 Year

Michael ChernyLeerink Partners

Success Rate

30/31 ratings generated profit

Average Return

+31.57%

reiterated a buy rating 3 months ago

Copying Michael Cherny's trades and holding each position for 1 Year would result in 96.77% of your transactions generating a profit, with an average return of +31.57% per trade.

2 Years

xxx

Success Rate

30/31 ratings generated profit

Average Return

+54.37%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 96.77% of your transactions generating a profit, with an average return of +54.37% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MCK Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MCK has received 14 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. MCK average Analyst price target in the past 3 months is 942.83.

Each month's total comprises the sum of three months' worth of ratings.

MCK Financial Forecast

MCK Earnings Forecast

Next quarter’s earnings estimate for MCK is $9.16 with a range of $9.05 to $9.31. The previous quarter’s EPS was $9.86. MCK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year MCK has Performed in-line its overall industry.

MCK Sales Forecast

Next quarter’s sales forecast for MCK is $105.87B with a range of $103.80B to $108.35B. The previous quarter’s sales results were $103.15B. MCK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year MCK has Performed in-line its overall industry.

MCK Stock Forecast FAQ

What is MCK’s average 12-month price target, according to analysts?

Based on analyst ratings, Mckesson Corp.’s 12-month average price target is 942.83.

What is MCK’s upside potential, based on the analysts’ average price target?

Mckesson Corp. has 15.74% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MCK a Buy, Sell or Hold?

Mckesson Corp. has a consensus rating of Strong Buy which is based on 11 buy ratings, 2 hold ratings and 0 sell ratings.

What is Mckesson Corp.’s price target?

The average price target for Mckesson Corp. is 942.83. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1,000.00 ,the lowest forecast is $880.00. The average price target represents 15.74% Increase from the current price of $814.63.

What do analysts say about Mckesson Corp.?

Mckesson Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of MCK?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

McKesson (MCK) Stock Forecast & Price Target

MCK Analyst Ratings

MCK Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering McKesson

MCK Analyst Recommendation Trends

MCK Financial Forecast

MCK Earnings Forecast

MCK Sales Forecast

MCK Stock Forecast FAQ

Detailed List of Analyst Forecasts